Consumer Raises Quality Concern Over Glucophage Tablet, Calls for Investigation
Disclaimer: This article reports on a claim made by a consumer on social media. The information has not been independently verified by NamakMandi.pk, and no official findings have been released by Martin Dow or the Drug Regulatory Authority of Pakistan (DRAP) regarding this specific allegation at the time of publication. The article is published in the public interest to raise awareness about medicine safety and does not imply wrongdoing or confirm a manufacturing defect. The article will be updated if official statements or investigation results become available.
A consumer has shared photographs on social media alleging the discovery of what appears to be a foreign object resembling a hair embedded in a Glucophage XR 750 mg (Metformin Hydrochloride) tablet manufactured by Martin Dow under licence from Merck KGaA.
According to the post, the individual has preserved the tablet, blister pack, batch details, and photographic evidence and has requested that both Martin Dow and the Drug Regulatory Authority of Pakistan (DRAP) investigate the matter.
The consumer stated that if the observation is confirmed through an official investigation, it could indicate a manufacturing or quality assurance issue. The post also urged other consumers to inspect their medicines before use and report any suspected defects to the manufacturer, pharmacy, or DRAP.
No Official Confirmation Yet
At the time of publishing, NamakMandi.pk has not independently verified the claim, and no official statement has been issued by Martin Dow or DRAP regarding this specific allegation.
It is important to note that a social media post alone does not confirm that a manufacturing defect has occurred. Only an investigation by the manufacturer and the relevant regulatory authorities can determine whether the tablet contains a genuine foreign material, whether contamination occurred during manufacturing, or whether another explanation exists.
What Should Patients Do?
Patients currently taking Glucophage XR (Metformin) should not stop their prescribed medication solely because of this social media post. Sudden discontinuation of diabetes medication may result in poor blood sugar control.
However, consumers are encouraged to:
- Inspect medicines before use.
- Avoid taking tablets that appear damaged, discoloured, or contain any suspected foreign material.
- Keep the original packaging and batch information if a defect is suspected.
- Contact their pharmacist or prescribing doctor for advice.
- Report suspected medicine quality defects to DRAP and the manufacturer.
Editorial Note: If you are taking Glucophage XR or any other prescribed medication, do not stop your treatment based solely on this report. If you notice any suspected quality issue with a medicine, consult your pharmacist or healthcare provider, retain the product and packaging if possible, and report the concern to the manufacturer and DRAP.
